Michael Benkowitz
Fortuna: 11 M $ al 31/08/2026
Fortuna: 11 M $ al 31/08/2026
Michael Ian Benkowitz es miembro del consejo de administración de United Therapeutics Europe Ltd. y Presidente y Director de Operaciones de United Therapeutics Corp.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 13/05/2026 | 21.756 ( 0,05 % ) | 11 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Presidente | 26/06/2016 |
| MIROMATRIX MEDICAL INC. | Director de Operaciones | 11/12/2023 |
United Therapeutics Europe Ltd.
United Therapeutics Europe Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical goods | Director/Miembro de la Junta | 23/08/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Miromatrix Medical, Inc.
Miromatrix Medical, Inc. BiotechnologyHealth Technology Engages in research and development of fully biologic organs | Health Technology |
United Therapeutics Europe Ltd.
United Therapeutics Europe Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical goods | Distribution Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.